In a 2020 systematic review of randomized trials, HBOT improved at least one post-surgical outcome in 10 of 13 studies (627 patients), while one trial found a negative effect (Boet, 2020). Benefit concentrates in high-risk wounds: compromised grafts and flaps, diabetic surgical wounds, irradiated tissue, and infected bone. For routine surgery in healthy patients the evidence does not support it, and insurance covers only the FDA-cleared indications.
Recovery from surgery depends heavily on oxygen delivery to healing tissue, and surgery itself disrupts that delivery through tissue trauma, anesthetic effects on circulation, and post-operative swelling. HBOT addresses this directly, and a growing number of patients use it as a post-surgical adjunct. Whether it is worth the time and cost depends on your specific procedure, your health status, and what the evidence says for your situation. This is one of several recovery applications for HBOT.
Why does surgery starve tissue of oxygen?
Every incision severs blood vessels, reducing oxygen supply to the tissue around the wound, and post-operative swelling compresses small capillaries, worsening local perfusion. In healthy patients with robust circulation, this is a temporary disruption the body compensates for. In patients with diabetes, peripheral vascular disease, or radiation damage, the deficit can be severe enough to prevent healing entirely.
HBOT dissolves oxygen directly into the plasma at levels well above normal, reaching tissue that standard hemoglobin-based delivery cannot adequately supply. This supports the metabolic demands of healing without requiring intact capillary perfusion. In the 2020 review by Boet and colleagues, 10 of 13 randomized trials (546 of 627 patients) found HBOT effective for at least one outcome, two found no benefit, and one found a negative effect, with the authors noting methodological limits such as limited sham comparators and lack of blinding.
Which surgeries does HBOT actually help?
Benefit is concentrated in high-risk wounds rather than routine procedures. Where circulation is already compromised, added tissue oxygen can make the difference between healing and breakdown; where circulation is intact, it usually adds little.
HBOT after surgery: role, evidence, and coverage
| Procedure or wound | HBOT role | Evidence | Coverage |
|---|---|---|---|
| Compromised skin graft or flap | FDA-cleared salvage of failing tissue | Moderate-Strong | Covered |
| Diabetic surgical wound | Adjunct to reduce dehiscence and infection | Moderate | Often covered |
| Surgery in irradiated tissue | Perioperative, before and after | Moderate | Covered |
| Osteomyelitis surgery | Adjunct after debridement | Moderate | Covered |
| Elective orthopedic surgery | Routine adjunct in healthy patients | Limited | Not covered |
| Cosmetic and plastic surgery | Reduce bruising and edema | Emerging | Not covered |
Compromised grafts and flaps are an FDA-cleared indication: when grafts fail to establish perfusion, HBOT can preserve marginal tissue and support neovascularization, and it works best when started promptly after signs of compromise appear. Diabetic patients face elevated surgical complication rates, and post-surgical HBOT has reduced wound dehiscence and infection in several studies, which connects to the broader diabetes and HBOT evidence. Surgery in previously irradiated tissue is high-risk because radiation-damaged vessels perfuse poorly, so HBOT is often used perioperatively in head and neck, breast, and pelvic reconstruction; the radiation damage article covers the mechanisms. Debridement of infected bone is frequently followed by HBOT, an approved indication detailed in the bone healing article.
The weaker-evidence uses are routine ones. Elective hip and knee replacement in healthy patients lacks robust support, because tissue with intact circulation generally heals adequately, though HBOT may reduce early swelling. The same reasoning applies to training recovery, covered in the HBOT for athletes guide, and to ligament repair. For cosmetic surgery, a 2025 meta-analysis by Mortada and colleagues of 11 studies (734 patients) reported a pooled mean healing time of 11.3 days with HBOT as an adjunct and high patient satisfaction, but the authors emphasized variable protocols and called for randomized trials before it becomes standard.
One consistent effect underpins several of these uses: at high tissue oxygen tensions, neutrophils and macrophages kill bacteria more effectively. A 2025 randomized trial by Zhang and colleagues in total knee arthroplasty patients found HBOT reduced postoperative muscle damage and inflammation markers, consistent with this anti-inflammatory and immune role. The HBOT for infections article covers the mechanism in detail.
How is a patient assessed before post-surgical HBOT?
Transcutaneous oxygen measurement (TCOM or TcPO2) is one of the most useful tools for deciding whether post-surgical HBOT is appropriate. This non-invasive test measures oxygen tension at the skin surface, giving a direct read on tissue perfusion at a specific location. A value below 40 mmHg in the wound area is generally considered hypoxic and predictive of poor healing, while values that rise substantially when the patient breathes 100% oxygen predict a better HBOT response. TCOM takes much of the guesswork out of patient selection and is standard at well-equipped hyperbaric programs.
HBOT supports healing biology, but that biology still needs nutritional substrates: adequate protein for collagen synthesis, vitamin C for collagen crosslinking, zinc for immune function, and sufficient calories. Post-surgical HBOT in complex cases should be managed at hospital-based or accredited outpatient programs that coordinate with the surgical team. When evaluating a facility, ask whether they perform TCOM assessments and whether they have experience with your specific complication. Post-surgical protocols typically run daily sessions (five days per week) for two to four weeks at 2.0 to 2.4 ATA, starting within the first days to two weeks after surgery.
Does insurance cover HBOT after surgery?
Coverage depends entirely on the indication. For approved post-surgical uses (compromised skin grafts, osteomyelitis, radiation tissue damage), insurance including Medicare generally covers HBOT. For off-label use such as elective-surgery recovery or routine healing support, coverage is almost never available. The insurance guide explains this landscape in detail.
Setting expectations matters, because post-surgical HBOT is most often used in genuinely difficult cases (compromised grafts, infected bone, irradiated tissue, diabetic wounds) where outcomes are uncertain regardless of treatment. HBOT improves the probability of a good outcome in these situations, but it does not guarantee one, and some patients still require additional procedures. Understanding that upfront supports better shared decision-making with the surgical and hyperbaric teams.
Frequently Asked Questions
When should HBOT start after surgery?
For wound-related applications, starting within the first one to two weeks post-operatively is typical. For compromised skin grafts, starting within 24 to 48 hours of identifying compromise is recommended, since earlier initiation lets HBOT influence the inflammatory and proliferative phases of healing more effectively. The exact timing should be coordinated between the surgical team and the hyperbaric physician based on the specific procedure and any contraindications.
Can HBOT help if my surgical wound isn’t healing?
Possibly, particularly if the wound is in tissue with compromised circulation. A hyperbaric physician can assess whether the wound has the characteristics (hypoxic but viable tissue) that typically respond to HBOT. A transcutaneous oxygen measurement (TCOM) of the wound is often done to guide this, since a low reading that improves on 100% oxygen predicts a better response to treatment.
Is HBOT safe right after surgery?
Generally yes, for most post-surgical patients once they are stable. Pneumothorax (collapsed lung) is a contraindication, so any air in the chest cavity from thoracic surgery must resolve first. Your surgical team and the hyperbaric physician should communicate to ensure appropriate timing. The side effects guide covers contraindications in detail.
Sources
- Boet S, Martin L, Cheng-Boivin O, et al. “Can preventive hyperbaric oxygen therapy optimise surgical outcome? A systematic review of randomised controlled trials.” European Journal of Anaesthesiology, 2020;37(8):636-648. doi.org/10.1097/EJA.0000000000001219
- Mortada H, González JE, Husseiny YM, et al. “Efficacy of Hyperbaric Oxygen Therapy as an Adjunct in Aesthetic Surgery: A Systematic Review and Meta-analysis.” Aesthetic Plastic Surgery, 2025;49(9):2498-2512. doi.org/10.1007/s00266-025-04728-9
- Zhang R, et al. “Effect of hyperbaric oxygen therapy on postoperative muscle damage and inflammation following total knee arthroplasty: a randomized controlled trial.” Scientific Reports, 2025. doi.org/10.1038/s41598-025-06223-2
- Undersea and Hyperbaric Medical Society. “Indications for Hyperbaric Oxygen Therapy” (compromised grafts and flaps; osteomyelitis; radiation tissue damage). uhms.org
- Mayo Clinic. “Hyperbaric oxygen therapy.” mayoclinic.org
Medical Disclaimer
The content on BaricBoost.com is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Author
Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.
